Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).
Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica.
Metabolic features of the cell danger response.
CHMP assessment report for Sovrima (International nonproprietary name: idebenone)
Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice.
Genzyme’s Lemtrada Approved in Argentina for Treatment of Multiple Sclerosis
Neuromyelitis optica.
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.
Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report.
Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway.
Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study.
Pilates based core stability training in ambulant individuals with multiple sclerosis: Protocol for a multi-centre randomised controlled trial.
T cells become licensed in the lung to enter the central nervous system.
Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy.
Anejaculatory infertility due to multiple sclerosis.
FDA warns about seizures linked to MS drug
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.
SMC Says Yes to Lemtrada(R)a- 1/4 (alemtuzumab) 12mg IV, a New Treatment for Adults with Active Relapsing Remitting-Multiple Sclerosis (RRMS)
Dispositional optimism is unidimensional or bidimensional? The Portuguese revised Life Orientation Test.
Alpha4-integrin antagonism--an effective approach for the treatment of inflammatory diseases?
Genmab announces details of planned ofatumumab Phase II study in multiple sclerosis

Pages